MedTrace Logo

LDART for Stimulant Use Disorder

NCT07221396 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-05-01

No results posted yet for this study

Summary

The goal of this study is to evaluate the feasibility, acceptability, and preliminary efficacy of a digital intervention called LDART in adults with stimulant use disorder.

Conditions

  • Stimulant Use Disorder
  • Cocaine Use Disorder
  • Methamphetamine Use Disorder

Interventions

DEVICE

LDART

Let's Do Addiction Recovery Together! (LDART) is a web-based intervention grounded in social cognitive theory that is designed to reduce hazardous alcohol use. It has three active ingredients: 1) daily recovery goal setting and tracking, 2) motivational video, audio, and written messages from individuals in recovery, and 3) information on several community-based recovery groups (e.g., mutual-help groups, recovery community centers) that provide free, publicly available meetings and activities. Participants receive a text message reminder each night to go to the website to complete the activities, and a text message reminder each morning of the goal they set for themselves, with the option to change it. It only takes a few minutes to use LDART each day over the 4-week intervention period.

BEHAVIORAL

Psychoeducational booklet

This is a 10-page PDF on stimulant use disorder created by the American Society of Addiction Medicine and American Academy of Addiction Psychiatry. It contains information about stimulant intoxication and withdrawal and treatment options. Participants will be encouraged to access this booklet for a few minutes each night over the 4-week intervention period.

Sponsors & Collaborators

  • College on Problems of Drug Dependence

    collaborator UNKNOWN

  • Yale University

    lead OTHER

Principal Investigators

  • Li Yan McCurdy, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-29
Primary Completion
2027-04-01
Completion
2027-04-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07221396 on ClinicalTrials.gov